Vicapsys Life Sciences, Inc. financial data

Symbol
VICP on OTC
Location
Cumming, GA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 10 Jan 2025

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity 58% % -39%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32,371,299 shares
Common Stock, Shares, Outstanding 32,371,299 shares 0.94%
Entity Public Float $4,658,159 USD
Common Stock, Value, Issued $32,371 USD 0.94%
Weighted Average Number of Shares Outstanding, Basic 34,327,600 shares -0.22%
Weighted Average Number of Shares Outstanding, Diluted 34,327,600 shares -0.22%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $14,090 USD 15%
General and Administrative Expense $92,251 USD 42%
Operating Income (Loss) $1,109,543 USD -9.3%
Nonoperating Income (Expense) $36,645 USD 44%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,347,472 USD -25%
Net Income (Loss) Attributable to Parent $1,347,472 USD -25%
Earnings Per Share, Basic 0 USD/shares -33%
Earnings Per Share, Diluted 0 USD/shares -33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $89,569 USD 67%
Assets, Current $89,569 USD -57%
Assets $89,569 USD -57%
Liabilities, Current $2,735,296 USD 77%
Retained Earnings (Accumulated Deficit) $17,052,745 USD -8.6%
Stockholders' Equity Attributable to Parent $2,645,727 USD -98%
Liabilities and Equity $89,569 USD -57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,422 USD 5.4%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 32,371,299 shares 0.94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $9,422 USD 5.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities $212 USD
Preferred Stock, Shares Authorized 7,440,000 shares -63%
Additional Paid in Capital $14,374,647 USD 0.27%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%